Patents by Inventor Kevin Guertin

Kevin Guertin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE
    Publication number: 20230348454
    Abstract: Provided herein are compounds and compositions thereof for modulating bis-phosphoglycerate mutase (BPGM) for treating sickle cell disease.
    Type: Application
    Filed: September 14, 2021
    Publication date: November 2, 2023
    Inventors: Kunal Desai, Zhong Fang, Kevin Guertin, Vu Hong, John Ziqi Jiang, Sungtaek Lim, Jinyu Liu, Mark Munson
  • CARBOXYLIC ACID-CONTAINING COMPOUNDS AS MODULATORS OF BIS-PHOSPHOGLYCERATE MUTASE FOR THE TREATMENT OF SICKLE CELL DISEASE
    Publication number: 20230348450
    Abstract: Provided herein are compounds and compositions thereof for modulating bis-phosphoglycerate mutase (BPGM) for treating sickle cell disease.
    Type: Application
    Filed: September 14, 2021
    Publication date: November 2, 2023
    Inventors: Kunal Desai, Zhong Fang, Kevin Guertin, Vu Hong, John Ziqi Jiang, Sungtaek Lim, Mark Munson
  • Substituted N-acyl-2-aminothiazoles
    Publication number: 20060030589
    Abstract: There are presented compounds of the formula or a pharmaceutically acceptable salt thereof, which are useful in the treatment of diabetes, diabetic retinopathy, asthma and diarrhea.
    Type: Application
    Filed: July 29, 2005
    Publication date: February 9, 2006
    Inventors: Jianping Cai, Adrian Cheung, Fariborz Firooznia, Kevin Guertin, Lida Qi